Clinical trials
Phase 2/3 Graft vs Host Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2 |
| Abgenix | 1 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
| Baxalta now part of Shire | 1 |
| Chimeric Therapies | 1 |
| Hospital Israelita Albert Einstein | 1 |
| Incyte Corporation | 1 |
| Kiadis Pharma | 1 |
| Rabin Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graft vs Host Disease | 14 |
| Myelodysplastic Syndromes | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Hematologic Neoplasms | 3 |
| Lymphoma | 3 |
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.